In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.
We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.
Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.
Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.
Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.
This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.
This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.
This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.
SAMU provides strategic, clinical and implementation support to various MSF projects with medical activities related to HIV and TB. This medical unit is based in Cape Town, South Africa.
BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.
Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.
Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.
Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.
The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.
The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.
The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.
A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.
On 18 November 2020, DRC declared their eleventh Ebola outbreak in 40 years over.
The outbreak, in the country’s northwest, in Équateur province, lasted just short of six months, having been declared on 1 June 2020.
The eleventh outbreak arrived as the Democratic Republic of Congo (DRC) declared a previous long-running outbreak of Ebola over in the country’s northeast, with cases first detected in August 2018.
That outbreak, in DRC's northeastern North Kivu, South Kivu and Ituri provinces, was the country's second outbreak that started in 2018 and the country's tenth Ebola outbreak in 40 years. Before it was declared over on 25 June 2020, the outbreak recorded 3,470 people infected and claimed nearly 2,300 lives. It remains the biggest outbreak ever in DRC, and the second-biggest ever.
The eleventh outbreak was the fourth Ebola epidemic since the end of the outbreak in West Africa in 2016 – and was the second epidemic in Équateur province in less than two years. The previous outbreak in Équateur province, between May and August 2018, which affected the city of Mbandaka, included 38 confirmed cases of Ebola and claimed 14 lives.
Improved medical response sees the end of DRC’s eleventh Ebola outbreak
19 Nov 2020
DRC Ebola outbreaks
Vaccinating against Ebola in a challenging context
Project Update3 Oct 2019
DRC Ebola outbreaks
Independent Ebola vaccination committee is needed to overcome lack of WHO transparency
Press Release23 Sep 2019
DRC Ebola outbreaks
10 facts on a year of Ebola in DRC
Project Update2 Aug 2019
DRC Ebola outbreaks
Tenth Ebola outbreak in DRC still rages, one year on
Voices from the Field1 Aug 2019
DRC Ebola outbreaks
DRC Ebola outbreak response struggling one year on
Project Update31 Jul 2019
DRC Ebola outbreaks
Not contained, new cases: three questions on vaccines and the Ebola outbreak in DRC
Interview31 Jul 2019
Democratic Republic of Congo
Restoring trust among communities fearful of Ebola
Project Update13 Jun 2019
Democratic Republic of Congo
Ebola response failing to gain the upper hand on the epidemic
Press Release7 Mar 2019
Democratic Republic of Congo
Medical activities suspended after Ebola treatment centre attack
Statement28 Feb 2019
DRC Ebola outbreaks
Second Ebola treatment centre in North Kivu attacked
Statement28 Feb 2019
DRC Ebola outbreaks
North Kivu: Ebola centre inoperative after violent attack
Press Release26 Feb 2019
DRC Ebola outbreaks
Potential new Ebola drugs being trialled in MSF treatment centres
Statement12 Feb 2019
Related topics
Africa
Democratic Republic of Congo
In DRC, MSF runs some of its largest medical relief operations, working in 17 of 26 provinces, responding to diseases outbreaks, conflict and displacement, and tackling health problems such as HIV/AIDs.
In 2019
3,800
people admitted to Ebola treatment centres
170
admitted patients confirmed as having Ebola
Medical Activities
Ebola and Marburg
Ebola and Marburg haemorrhagic fevers are rare but deadly. Outbreaks can kill 25 to 90 per cent of those infected, spreading fear and panic among affected communities.
Crisis Settings
Epidemics and pandemics
Millions of people still die each year from infectious diseases that are preventable or can be treated.
